These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31155531)

  • 1. [Problems with Laboratory Notebooks in Academia and How to Resolve Them].
    Kakuta H
    Yakugaku Zasshi; 2019; 139(6):887-890. PubMed ID: 31155531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research Reliability Required in Academia].
    Sudo H
    Yakugaku Zasshi; 2019; 139(6):891-898. PubMed ID: 31155532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK
    PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Towards Further Sharing of Knowledge and Activities on Standards of Quality Assurance (QA) across Industry, Academia and Government to Promote Research Integrity and Accelerate Drug Discovery].
    Kakuta H; Sudo H
    Yakugaku Zasshi; 2019; 139(6):873-874. PubMed ID: 31155528
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assurance mechanisms for the unregulated research environment.
    Riedl DH; Dunn MK
    Trends Biotechnol; 2013 Oct; 31(10):552-4. PubMed ID: 24054820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consideration on Academia Environments for Creating Medical Innovation].
    Iida K; Ishida T; Nishimura N
    Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-intellectual effects of intellectual property.
    Lipinski CA
    Curr Opin Chem Biol; 2006 Aug; 10(4):380-3. PubMed ID: 16829159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Requirements for the license-out of drug candidates to pharmaceutical companies].
    Tawara S; Kobayashi N; Arai H; Masumi S; Itoh S; Nakahara Y; Morimoto N; Itano Y; Yamaguchi T; Niwa K; Seki J; Nakamura K
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):198-202. PubMed ID: 24717609
    [No Abstract]   [Full Text] [Related]  

  • 10. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotechnology and new companies arising from academia.
    Vallance P
    Lancet; 2001 Nov; 358(9295):1804-6. PubMed ID: 11734259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Academia and industry: allocating credit for discovery and development of new therapies.
    Flier JS
    J Clin Invest; 2019 May; 129(6):2172-2174. PubMed ID: 31107243
    [No Abstract]   [Full Text] [Related]  

  • 16. The Academic-Industrial Complexity: Failure to Launch.
    Levin LA; Behar-Cohen F
    Trends Pharmacol Sci; 2017 Dec; 38(12):1052-1060. PubMed ID: 29111229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Good Laboratory Practice: Initial Development, Necessity, and Issues of Data Reliability in Basic Research].
    Ito K; Someya H
    Yakugaku Zasshi; 2019; 139(6):875-879. PubMed ID: 31155529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can we improve the translational landscape for a faster cure of type 1 diabetes?
    von Herrath M; Chan A
    J Clin Invest; 2009 May; 119(5):1061-5. PubMed ID: 19422092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTS and hit finding in academia--from chemical genomics to drug discovery.
    Frearson JA; Collie IT
    Drug Discov Today; 2009 Dec; 14(23-24):1150-8. PubMed ID: 19793546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to set up collaborations between academia and industrial biotech companies.
    Pronk JT; Lee SY; Lievense J; Pierce J; Palsson B; Uhlen M; Nielsen J
    Nat Biotechnol; 2015 Mar; 33(3):237-40. PubMed ID: 25748909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.